ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,531Medicare Part D Prescriptions Filled, Including Refills

Rank: 300 out of 1383

$511K Total Retail Price of All Prescriptions

Rank: 339 out of 1383

496 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
50% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 496 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

16% of this provider’s 496 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

4% of this provider’s 7,417 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
SIMVASTATIN 522 385 1 2
OMEPRAZOLE 410 296 2 5
METFORMIN HCL 345 260 3 8
HYDROCODONE-ACETAMINOPHEN 334 210 S3 4 1
LISINOPRIL 334 250 4 3
ZOLPIDEM TARTRATE 304 180 6 17
TRAMADOL HCL 282 198 7 25
LEVOTHYROXINE SODIUM 219 140 8 4
HYDROCHLOROTHIAZIDE 198 177 9 10
FUROSEMIDE 197 118 10 7
POTASSIUM CHLORIDE 194 163 11 12
ATENOLOL 185 150 12 16
GABAPENTIN 179 86 13 11
WARFARIN SODIUM 174 127 14 13
AMLODIPINE BESYLATE 173 163 15 6
ATORVASTATIN CALCIUM 152 115 16 18
GLIPIZIDE 135 106 17 98
NEXIUM 133 82 18 26
METOPROLOL TARTRATE 114 64 19 9
LISINOPRIL-HYDROCHLOROTHIAZIDE 111 87 20 27
TRAZODONE HCL 103 61 21 36
PROMETHAZINE HCL 96 47 R 22 56
PANTOPRAZOLE SODIUM 92 83 23 32
CYCLOBENZAPRINE HCL 86 70 R 24 69
PREDNISONE 85 62 25 40
NABUMETONE 84 80 26 156
RANITIDINE HCL 82 41 27 19
AMITRIPTYLINE HCL 81 48 R 28 57
AZITHROMYCIN 79 62 29 41
CARVEDILOL 78 65 30 24
SERTRALINE HCL 76 52 31 21
DILTIAZEM ER 76 72 31 110
PROAIR HFA 74 44 33 42
ENDOCET 74 40 S2 33 97
OXYCODONE HCL 73 0 S2 35 62
CIPROFLOXACIN HCL 71 48 36 54
COMBIVENT 66 24 37 116
AMOXICILLIN 65 34 38 119
CRESTOR 64 45 39 34
SULFAMETHOXAZOLE-TRIMETHOPRIM 64 45 39 89
ALLOPURINOL 63 50 41 33
CLONIDINE HCL 59 51 42 44
LANTUS 57 32 43 50
ACETAMINOPHEN-CODEINE 55 47 S3 44 163
OXYBUTYNIN CHLORIDE 55 28 44 115
METOPROLOL SUCCINATE 54 38 46 29
CLOPIDOGREL 54 43 46 28
HYDROXYZINE HCL 54 36 R 46 151
DILTIAZEM 24HR CD 50 46 49 95
PRAVASTATIN SODIUM 50 46 49 14
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 28, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.